OXiGENE Announces First Quarter 2013 Earnings Conference Call and Webcast

OXiGENE Announces First Quarter 2013 Earnings Conference Call and Webcast

SOUTH SAN FRANCISCO, Calif., April 24, 2013 (GLOBE NEWSWIRE) -- OXiGENE, Inc.
(Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel
therapeutics to treat cancer, will report first quarter 2013 results on
Monday, May 6, 2013. A conference call and webcast hosted by OXiGENE
management will begin at 4:30 pm ET (1:30 p.m. PT).

OXiGENE's earnings conference call can be heard live by dialing (888) 841-3431
in the United States and Canada, and +1 (678) 809-1060 for international
callers, five minutes prior to the beginning of the call.

To listen to a live or archived version of the audio webcast, please log on to
the Company's website, www.oxigene.com. Under the "Investors" tab, select the
link to "Events & Presentations."

About OXiGENE

OXiGENE is a clinical-stage biopharmaceutical company developing novel
therapeutics to treat cancer. The Company's major focus is developing vascular
disrupting agents that selectively disrupt abnormal blood vessels associated
with solid tumor progression. OXiGENE is dedicated to leveraging its
intellectual property and therapeutic development expertise to bring
life-extending and life-enhancing medicines to patients.

CONTACT: Investor and Media Contact:
         ir@oxigene.com
         650-635-7000

company logo
 
Press spacebar to pause and continue. Press esc to stop.